Substance / Medication

Dexbrompheniramine

Overview

Active Ingredient
dexbrompheniramine
RxNorm CUI
22696

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Evaluation of Pharmacological Treatments for Acute Urticaria: A Systematic Review and Meta-Analysis.
Jamjanya Sirinda, Danpanichkul Pojsakorn, Ongsupankul Sorawit et al. · J Allergy Clin Immunol Pract · 2024
PMID: 38280453Meta-Analysis
Maternal Common Cold or Fever During Pregnancy and the Risk of Orofacial Clefts in the Offspring: A Systematic Review and Meta-analysis.
Shi Fang-Ping, Huang Ying-Ying, Dai Qiao-Qun et al. · Cleft Palate Craniofac J · 2023
PMID: 34918551Meta-Analysis
Transmission route of rhinovirus - the causative agent for common cold. A systematic review.
Andrup Lars, Krogfelt Karen A, Hansen Kristian Schultz et al. · Am J Infect Control · 2023
PMID: 36535318Meta-Analysis
Herbal Medicines for Rhinosinusitis: A Systematic Review and Network Meta-analysis.
Hoang Minh Phuoc, Seresirikachorn Kachorn, Chitsuthipakorn Wirach et al. · Curr Allergy Asthma Rep · 2023
PMID: 36609950Meta-Analysis
Immediate versus delayed versus no antibiotics for respiratory infections.
Spurling Geoffrey Kp, Dooley Liz, Clark Justin et al. · Cochrane Database Syst Rev · 2023
PMID: 37791590Meta-AnalysisFull text (PMC)
Vitamin C reduces the severity of common colds: a meta-analysis.
Hemilä Harri, Chalker Elizabeth · BMC Public Health · 2023
PMID: 38082300Meta-AnalysisFull text (PMC)
Potentialities of ITP-CZE method with diode array detection for enantiomeric purity control of dexbrompheniramine in pharmaceuticals.
Marák Jozef, Mikus Peter, Maráková Katarína et al. · J Pharm Biomed Anal · 2008
PMID: 17618074Other
Transient receptor potential vanilloid-1-mediated calcium responses are inhibited by the alkylamine antihistamines dexbrompheniramine and chlorpheniramine.
Sadofsky Laura R, Campi Barbara, Trevisani Marcello et al. · Exp Lung Res · 2008
PMID: 19085565Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dexbrompheniramine (substance)
SNOMED CT
387429005
UMLS CUI
C0057605
RxNorm CUI
22696

Clinical Data

This intervention maps to 4 entities in the Healos knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Dexbrompheniramine — Conditions, Biomarkers & Specialists | Healos | Ltrl